Triamterene And Hydrochlorothiazide Capsule
Product Images NDC 51655-722

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 51655-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 722 52 Master Bottle Label Approval Rev A 06 21)

Label for Triamterene and Hydrochlorothiazide Capsules, USP 37.5 mg / 25 mg, containing 30 capsules. The label indicates prescription use only, storage instructions, and is labeled by Northwind Pharmaceuticals. It includes NDC 51655-722-52 and manufacturer information from Sandoz Inc.*

FDA Label Image

Hctz_chemical_structure (Hctz Chemical Structure)

Chemical structure diagram of the active ingredient Triamterene, depicting its molecular arrangement including a chlorophenyl group, sulfonamide, and other characteristic functional groups.*

FDA Label Image

Triamterene_chemical_structure (Triamterene Chemical Structure)

Chemical structure diagram of Triamterene, one of the active ingredients in the product Triamterene and Hydrochlorothiazide capsules. The structure displays multiple aromatic rings and amino groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.